Zhitong Finance App News, Jingfang Pharmaceutical-B (02595.HK) announced that the company will hold an online investor conference on October 15, 2026 to announce preliminary research data on the treatment of KRAS G12D mutant solid tumors with the product GFH375 (KRAS G12D inhibitor) combined with cetuximab under development.
智通財經·09/23/2026 00:17:07
語音播報
Zhitong Finance App News, Jingfang Pharmaceutical-B (02595.HK) announced that the company will hold an online investor conference on October 15, 2026 to announce preliminary research data on the treatment of KRAS G12D mutant solid tumors with the product GFH375 (KRAS G12D inhibitor) combined with cetuximab under development.